CordenPharma Plankstadt announced the design and installment of a new manufacturing line dedicated to producing Veterinary Drug Products for 500kg scale batch sizes to supply a complex product for application in the veterinary health market. This new line is part of a production plant that is dedicated to Veterinary Drug Products.
The expansion of the production capabilities at CordenPharma Plankstadt are the result of a new, long-term custom manufacturing agreement for an animal health application, which the company recently signed. Work will commence in the second quarter of 2017, with a targeted mechanical completion by the 2nd quarter of 2018 and commercial supply for the global launch campaign planned to start in the second half of 2018. CordenPharma Plankstadt has supported the customer over the last year and a half, from initial technology transfer and development activities to the timely manufacturing of registration batches.
“This is an extremely important and significant investment for CordenPharma Plankstadt. This new production line will allow the fully contained handling of highly potent APIs in a dedicated facility for the manufacturing of Veterinary Drug Products. This is a unique opportunity in the industry,” said Frank Hähner, Managing Director of CordenPharma Plankstadt.